| P50 | author | Marta Busnelli | Q57420675 |
| | Céline Galès | Q73251493 |
| | Michel Bouvier | Q38326685 |
| | Bice Chini | Q39691750 |
| P2093 | author name string | Celine Galés | |
| | Aude Saulière | |
| | Maurice Manning | |
| P2860 | cites work | Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin | Q41150726 |
| | Analysis by mRNA levels of the expression of six G protein alpha-subunit genes in mammalian cells and tissues | Q41665833 |
| | Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus | Q41960221 |
| | Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: involvement of pertussis toxin-sensitive and -insensitive G-proteins | Q42507704 |
| | Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells | Q42507719 |
| | Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. | Q42595255 |
| | Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas | Q42631120 |
| | The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions | Q42678379 |
| | Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways | Q44904251 |
| | The oxytocin receptor antagonist atosiban inhibits cell growth via a "biased agonist" mechanism | Q45261068 |
| | Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban | Q46478518 |
| | Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. | Q47193947 |
| | Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity. The Litchfield Lecture | Q48576708 |
| | Scientists probe oxytocin therapy for social deficits in autism, schizophrenia | Q50312740 |
| | Internalization and desensitization of the oxytocin receptor is inhibited by Dynamin and clathrin mutants in human embryonic kidney 293 cells. | Q53656341 |
| | Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis | Q56648628 |
| | Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response | Q57369934 |
| | Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family | Q71275084 |
| | Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families | Q73811998 |
| | Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis | Q77933665 |
| | Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1 | Q84090140 |
| | Functional Selectivity and Classical Concepts of Quantitative Pharmacology | Q22242288 |
| | Phosphorylation-independent desensitization of GABA(B) receptor by GRK4 | Q24671065 |
| | Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis* | Q28208920 |
| | Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin | Q28237545 |
| | Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents | Q28288577 |
| | Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor | Q28368136 |
| | Coupling of oxytocin receptor to G proteins in rat myometrium during labor: Gi receptor interaction | Q28578269 |
| | Oxytocin receptors differentially signal via Gq and Gi proteins in pregnant and nonpregnant rat uterine myocytes: implications for myometrial contractility | Q30483332 |
| | Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling | Q33534900 |
| | The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior | Q33761364 |
| | Teaching old receptors new tricks: biasing seven-transmembrane receptors | Q33985759 |
| | An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects | Q34164718 |
| | A Gly/Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists. | Q34383214 |
| | Real-time monitoring of receptor and G-protein interactions in living cells. | Q34405296 |
| | Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output | Q34549716 |
| | An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization | Q34580057 |
| | Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) | Q35120622 |
| | Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors | Q36160942 |
| | Seven-transmembrane receptor signaling through beta-arrestin | Q36305171 |
| | Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue | Q36671779 |
| | Oxytocin Induces the Migration of Prostate Cancer Cells: Involvement of the Gi-Coupled Signaling Pathway | Q39675130 |
| | Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor | Q39691630 |
| | Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. | Q39827773 |
| | Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 "short cycle". | Q39898138 |
| | Dopamine receptor-interacting protein 78 acts as a molecular chaperone for Ggamma subunits before assembly with Gbeta | Q40158543 |
| | Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3. | Q40173381 |
| | The DRY motif as a molecular switch of the human oxytocin receptor. | Q40393618 |
| | Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. | Q40420767 |
| | Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas. | Q40514478 |
| | Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains | Q40637745 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oxytocin | Q169960 |
| | protein family | Q417841 |
| P304 | page(s) | 3617-3629 | |
| P577 | publication date | 2011-11-08 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes | |
| P478 | volume | 287 | |